Pharma News, 2024

The US Food and Drug Administration (FDA) has granted fast-track designation to Bayer subsidiary Asklepios BioPharmaceutical’s (AskBio) investigational gene therapy AB-1002, aimed at...

The future of cell and gene therapy access in Europe could be more precarious than across the pond.

Moderna shares are trading in the red on Friday, on track for the eighth consecutive day of losses. Stock down 1.28% at $100.70. MRNA has lost about 29.6% in the last 12 months and YTD, the st...

Hot on the heels of a US Food and Drug Administration (FDA) approval for Alvotech and Teva Pharmaceuticals’ Simlandi (adalimumab-ryvk), Alvotech has announced a long-term agreement w...

Genentech, a member of the Roche Group, announced today that the U.S.

Shares of Eli Lilly (LLY) are slightly above their flatline Wednesday morning after the pharmaceutical giant announced positive results from a clinical trial of GLP-1 its weight loss drug Zepb...

Speciality pharmaceutical group Essential Pharma has concluded the acquisition of Reminyl (Galantamine) oral capsules from Johnson & Johnson company Janssen Pharmaceutica.

GSK plc GSK announced that the FDA has accepted its biologics license application (BLA) seeking approval of its 5-in-1 meningococcal ABCWY vaccine candidate, MenABCWY. The FDA has granted a st...

DENVER — The American Brain Foundation is funding research to find a cure for Lewy body dementia and discover breakthroughs in neuroinflammation, the group’s executive director said at the America...

Alvotech and Teva Pharmaceuticals have announced approval from the US Food and Drug Administration (FDA) for Selarsdi (ustekinumab-aekn) via subcutaneous injection. Selarsdi is a Stela...

Glenmark Pharmaceuticals’ US-based unit has announced the recall of 6,528 bottles of Diltiazem Hydrochloride extended-release capsules for treating high blood pressure.

Researchers from the Institute of Cancer Research (ICR) have discovered a new way to convert inhibitor-style targeted cancer drugs into degraders, small molecules, to destroy cancer-promoting proteins...